IGC Pharma, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2023
Total Assets: $17.2M
Liabilities Breakdown FY2023
Total Liabilities: $2.3M
Asset Breakdown
Total Assets: $17.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.2M | 18.6% |
| Accounts Receivable | $107.0K | 0.6% |
| Inventory | $2.7M | 15.4% |
| Property, Plant & Equipment | $8.2M | 47.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $1.2M | 6.8% |
| Other Assets | $1.8M | 10.7% |
Liabilities Breakdown
Total Liabilities: $2.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $530.0K | 23.4% |
| Long-Term Debt | $141.0K | 6.2% |
| Other Liabilities | $1.6M | 70.4% |